1
|
Michiba A, Gi M, Yokohira M, Sakurai E, Teramoto A, Kiriyama Y, Yamada S, Wanibuchi H, Tsukamoto T. Early detection of genotoxic hepatocarcinogens in rats using γH2AX and Ki-67: prediction by machine learning. Toxicol Sci 2023; 195:202-212. [PMID: 37527026 DOI: 10.1093/toxsci/kfad073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/03/2023] Open
Abstract
Direct DNA double-strand breaks result in phosphorylation of H2AX, a variant of the histone H2 protein. Phosphorylated H2AX (γH2AX) may be a potential indicator in the evaluation of genotoxicity and hepatocarcinogenicity. In this study, γH2AX and Ki-67 were detected in the short-term responses (24 h after chemical administration) to classify genotoxic hepatocarcinogens (GHs) from non-GH chemicals. One hundred and thirty-five 6-week-old Crl: CD(SD) (SPF) male rats were treated with 22 chemicals including 11 GH and 11 non-GH, sacrificed 24 h later, and immunostained with γH2AX and Ki-67. Positivity rates of these markers were measured in the 3 liver ZONEs 1-3; portal, lobular, and central venous regions. These values were input into 3 machine learning models-Naïve Bayes, Random Forest, and k-Nearest Neighbor to classify GH and non-GH using a 10-fold cross-validation method. All 11 and 10 out of 11 GH caused significant increase in γH2AX and Ki-67 levels, respectively (P < .05). Of the 3 machine learning models, Random Forest performed the best. GH were identified with 95.0% sensitivity (76/80 GH-treated rats), 90.9% specificity (50/55 non-GH-treated rats), and 90.0% overall correct response rate using γH2AX staining, and 96.2% sensitivity (77/80), 81.8% specificity (45/55), and 90.4% overall correct response rate using Ki-67 labeling. Random Forest model using γH2AX and Ki-67 could independently predict GH in the early stage with high accuracy.
Collapse
Affiliation(s)
- Ayano Michiba
- Department of Diagnostic Pathology, Graduate School of Medicine, Fujita Health University, Toyoake, Aichi 470-1192, Japan
| | - Min Gi
- Department of Environmental Risk Assessment, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Osaka 545-8585, Japan
| | - Masanao Yokohira
- Departments of Medical Education and Pathology and Host-Defense, Faculty of Medicine, Kagawa University, Miki-cho, Kagawa 761-0793, Japan
| | - Eiko Sakurai
- Department of Diagnostic Pathology, Graduate School of Medicine, Fujita Health University, Toyoake, Aichi 470-1192, Japan
| | - Atsushi Teramoto
- Faculty of Information Engineering, Meijo University, Nagoya, Aichi 468-8502, Japan
| | - Yuka Kiriyama
- Department of Diagnostic Pathology, Graduate School of Medicine, Fujita Health University, Toyoake, Aichi 470-1192, Japan
- Department of Pathology, Narita Memorial Hospital, Toyohashi, Aichi 441-8029, Japan
| | - Seiji Yamada
- Department of Diagnostic Pathology, Graduate School of Medicine, Fujita Health University, Toyoake, Aichi 470-1192, Japan
| | - Hideki Wanibuchi
- Department of Molecular Pathology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Osaka 545-8585, Japan
| | - Tetsuya Tsukamoto
- Department of Diagnostic Pathology, Graduate School of Medicine, Fujita Health University, Toyoake, Aichi 470-1192, Japan
| |
Collapse
|
2
|
Yamada T, Toyoda T, Matsushita K, Akane H, Morikawa T, Cho YM, Ogawa K. Persistent γ-H2AX formation and expression of stem cell markers in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats. Toxicol Sci 2022; 189:51-61. [PMID: 35771629 DOI: 10.1093/toxsci/kfac064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
We investigated γ-H2AX formation, a biomarker of DNA damage, and expression of stem cell markers (SCMs), including cytokeratin 14, aldehyde dehydrogenase 1A1 (ALDH1A1), and CD44, in the development of rat bladder tumors induced by short-term administration of N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN). Histopathological examination showed that diffuse simple hyperplasia of the bladder urothelium induced by BBN recovered to the normal-appearing urothelium after withdrawal, whereas focal proliferative lesions were newly developed and subsequently progressed to benign papilloma and carcinoma. Immunohistochemical analysis revealed that BBN-induced γ-H2AX formation and ALDH1A1 and CD44 expression persisted at higher levels in the normal-appearing urothelium than those in the control group for long periods after withdrawal. Since persistent chronic inflammation was observed even after withdrawal, targeted gene expression analysis of inflammation-related factors revealed 101 genes, including Stat3 and Myc, that showed persistent high expression. Pathway analysis suggested that Stat3 and/or Myc activation may be associated with SCM expression. We focused on hepatocyte growth factor (Hgf), one of the genes predicted in relation to Stat3/Myc, and confirmed that HGF-positive cells increased by BBN persisted in the normal-appearing urothelium after withdrawal and colocalized with γ-H2AX and SCMs. These results suggested that the long-term persistence of γ-H2AX formation and SCM expression, which occurred during the early stages of bladder tumorigenesis, is not a transient response to exposure and might contribute to bladder tumorigenesis. Although further studies are needed, BBN-induced rat bladder tumors may originate from focal hyperplasia arising from SCM-positive cells via activation of the STAT3/MYC pathway after DNA damage involving γ-H2AX formation.
Collapse
Affiliation(s)
- Takanori Yamada
- Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, 210-9501, Japan.,Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo, 183-8509, Japan
| | - Takeshi Toyoda
- Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, 210-9501, Japan
| | - Kohei Matsushita
- Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, 210-9501, Japan
| | - Hirotoshi Akane
- Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, 210-9501, Japan
| | - Tomomi Morikawa
- Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, 210-9501, Japan
| | - Young-Man Cho
- Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, 210-9501, Japan
| | - Kumiko Ogawa
- Division of Pathology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, 210-9501, Japan
| |
Collapse
|
3
|
Ogawa K, Ishii Y, Toyoda T. [Role and potential of histopathological specimens in the toxicological evaluation of pharmaceuticals and chemicals]. Nihon Yakurigaku Zasshi 2022; 157:139-145. [PMID: 35228447 DOI: 10.1254/fpj.21102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
With the development of molecular-targeted drugs, the demand for utilization of histopathological specimens and pathological diagnosis is increasing in the field of clinical pathology. In particular, in case of companion diagnostics, the results of immunohistochemical staining have become beyond diagnostic assistance, definitive diagnosis, and now indispensable for selection of therapeutic agents. Histopathological examination also serves an important role in non-clinical toxicological evaluation. Particularly, it is pivotal for obtaining data on organ-specific toxicity and carcinogenicity. On the other hand, a weight of evidence approach is currently being considered in International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) S1 as an option to replace the 2-year rat carcinogenicity study, in which case the evaluation of the 26-week-repeated dose toxicity study will be more important. In this article, We would like to introduce the usefulness of γ-H2AX-based rat bladder carcinogenicity evaluation using histopathological specimens obtain from 28-day repeated-dose study and the application of mass spectrometric imaging currently under consideration in our laboratory, thus discuss the role of histopathological examination in non-clinical toxicological and safety evaluation and its future perspective.
Collapse
Affiliation(s)
- Kumiko Ogawa
- Division of Pathology, National Institute of Health Sciences
| | - Yuji Ishii
- Division of Pathology, National Institute of Health Sciences
| | - Takeshi Toyoda
- Division of Pathology, National Institute of Health Sciences
| |
Collapse
|
4
|
Expression of stem cell markers as useful complementary factors in the early detection of urinary bladder carcinogens by immunohistochemistry for γ-H2AX. Arch Toxicol 2020; 95:715-726. [PMID: 33211169 DOI: 10.1007/s00204-020-02950-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2020] [Accepted: 11/05/2020] [Indexed: 12/24/2022]
Abstract
We previously demonstrated that immunohistochemistry for γ-H2AX, a biomarker of DNA damage, is useful for early detection of urinary bladder carcinogens in rats. In a 28-day repeated-dose study, γ-H2AX was shown to have high sensitivity for detection of bladder carcinogens. However, no reports have evaluated whether a combination of multiple biomarkers may further improve sensitivity. Accordingly, in this study, we aimed to evaluate the applicability of bladder tissue and cancer stem cell markers, including cytokeratin 14 (KRT14), aldehyde dehydrogenase 1A1 (ALDH1A1), and cluster of differentiation 44 (CD44), as complementary markers for early detection of bladder carcinogens. Bladder samples obtained from male F344 rats orally treated with 14 bladder carcinogens and five nonbladder carcinogens for 28 days were used for immunohistochemical analysis of stem cell markers. In the bladder carcinogen-treated rats, increases in KRT14, ALDH1A1, and CD44 expression were observed in 9, 10, and 10 out of 14 groups, respectively, whereas the five nonbladder carcinogens did not cause upregulation of these markers. Although most epithelial cells with KRT14 or ALDH1A1 expression were also positive for CD44, KRT14 and ALDH1A1 expression were mutually exclusive. Twelve bladder carcinogens showed increases in at least one of the three markers, indicating that the combined evaluation showed higher sensitivity than the use of individual markers alone. Importantly, two of three bladder carcinogens that did not induce γ-H2AX immunostaining showed stem cell marker expression. Our results demonstrated that these stem cell markers may be useful as complementary markers for γ-H2AX in evaluation of bladder carcinogens.
Collapse
|
5
|
Suzuki S, Gi M, Toyoda T, Kato H, Naiki-Ito A, Kakehashi A, Ogawa K, Takahashi S, Wanibuchi H. Role of γ-H2AX as a biomarker for detection of bladder carcinogens in F344 rats. J Toxicol Pathol 2020; 33:279-285. [PMID: 33239845 PMCID: PMC7677623 DOI: 10.1293/tox.2020-0038] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2020] [Accepted: 07/29/2020] [Indexed: 12/24/2022] Open
Abstract
Phosphorylation of histone H2AX at serine 139 (γ-H2AX) is known to be induced by direct DNA damage or cellular metabolic imbalances and malfunctions. Previous studies have reported that γ-H2AX is a useful biomarker for early detection of genotoxic bladder carcinogens in rats. The purpose of the present study was to determine the role of γ-H2AX as a biomarker for detection of non-genotoxic bladder carcinogens in rats. Six-week-old male F344 rats were treated with 15 different chemicals for 4 weeks. Immunohistochemical analyses revealed that all three genotoxic bladder carcinogens and six out of seven non-genotoxic bladder carcinogens significantly increased γ-H2AX formation in the bladder urothelium of rats. In addition, four out of five rat bladder noncarcinogens did not increase γ-H2AX formation in the bladder urothelium regardless of genotoxicity. These results suggest that γ-H2AX is a useful biomarker for detection of both genotoxic and non-genotoxic bladder carcinogens in rats.
Collapse
Affiliation(s)
- Shugo Suzuki
- Department of Molecular Pathology, Osaka City University
Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan
- Department of Experimental Pathology and Tumor Biology,
Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-Cho,
Mizuho-Ku, Nagoya, Aichi 467-8601, Japan
| | - Min Gi
- Department of Molecular Pathology, Osaka City University
Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan
- Department of Environmental Risk Assessment, Osaka City
University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585,
Japan
| | - Takeshi Toyoda
- Division of Pathology, National Institute of Health
Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa 210-9501, Japan
| | - Hiroyuki Kato
- Department of Experimental Pathology and Tumor Biology,
Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-Cho,
Mizuho-Ku, Nagoya, Aichi 467-8601, Japan
| | - Aya Naiki-Ito
- Department of Experimental Pathology and Tumor Biology,
Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-Cho,
Mizuho-Ku, Nagoya, Aichi 467-8601, Japan
| | - Anna Kakehashi
- Department of Molecular Pathology, Osaka City University
Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan
| | - Kumiko Ogawa
- Division of Pathology, National Institute of Health
Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa 210-9501, Japan
| | - Satoru Takahashi
- Department of Experimental Pathology and Tumor Biology,
Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-Cho,
Mizuho-Ku, Nagoya, Aichi 467-8601, Japan
| | - Hideki Wanibuchi
- Department of Molecular Pathology, Osaka City University
Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan
| |
Collapse
|